Fimasartan attenuates renal ischemia-reperfusion injury by modulating inflammation-related apoptosis

Fimasartan, a new angiotensin II receptor antagonist, reduces myocyte damage and stabilizes atherosclerotic plaque through its anti-inflammatory effect in animal studies. We investigated the protective effects of pretreatment with fimasartan on ischemia-reperfusion injury (IRI) in a mouse model of i...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Korean J Physiol Pharmacol
Hlavní autoři: Cho, Jang-Hee, Choi, Soon-Youn, Ryu, Hye-Myung, Oh, Eun-Joo, Yook, Ju-Min, Ahn, Ji-Sun, Jung, Hee-Yeon, Choi, Ji-Young, Park, Sun-Hee, Kim, Chan-Duck, Kim, Yong-Lim
Médium: Artigo
Jazyk:Inglês
Vydáno: The Korean Physiological Society and The Korean Society of Pharmacology 2018
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6205936/
https://ncbi.nlm.nih.gov/pubmed/30402026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4196/kjpp.2018.22.6.661
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky